396 related articles for article (PubMed ID: 25174598)
1. [Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention].
Volpe M; Abrignani MG; Borghi C; Coccheri S; Gresele P; Patti G; Trimarco B; De Caterina R
G Ital Cardiol (Rome); 2014; 15(7-8):442-51. PubMed ID: 25174598
[TBL] [Abstract][Full Text] [Related]
2. Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis.
Halvorsen S; Andreotti F; ten Berg JM; Cattaneo M; Coccheri S; Marchioli R; Morais J; Verheugt FW; De Caterina R
J Am Coll Cardiol; 2014 Jul; 64(3):319-27. PubMed ID: 25034070
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
4. Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?
Matthys F; De Backer T; De Backer G; Stichele RV
Eur J Prev Cardiol; 2014 Mar; 21(3):354-65. PubMed ID: 23610452
[TBL] [Abstract][Full Text] [Related]
5. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
Gilpin VL; ; ;
J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
[No Abstract] [Full Text] [Related]
6. Aspirin in the treatment and prevention of cardiovascular disease: past and current perspectives and future directions.
Hennekens CH; Dalen JE
Am J Med; 2013 May; 126(5):373-8. PubMed ID: 23499330
[TBL] [Abstract][Full Text] [Related]
7. Reinitiating aspirin therapy for primary prevention of cardiovascular events in a patient post-aspirin-induced upper gastrointestinal bleed: a case report and review of literature.
Adly G; Plakogiannis R
Ann Pharmacother; 2013 Feb; 47(2):e8. PubMed ID: 23386069
[TBL] [Abstract][Full Text] [Related]
8. Aspirin for primary prevention: yes or no?
Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
[TBL] [Abstract][Full Text] [Related]
9. Aspirin overprescription in primary cardiovascular prevention.
Manes C; Giacci L; Sciartilli A; D'Alleva A; De Caterina R
Thromb Res; 2006; 118(4):471-7. PubMed ID: 16321425
[TBL] [Abstract][Full Text] [Related]
10. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
11. Aspirin for Primary Prevention of Cardiovascular Events.
Abdelaziz HK; Saad M; Pothineni NVK; Megaly M; Potluri R; Saleh M; Kon DLC; Roberts DH; Bhatt DL; Aronow HD; Abbott JD; Mehta JL
J Am Coll Cardiol; 2019 Jun; 73(23):2915-2929. PubMed ID: 31196447
[TBL] [Abstract][Full Text] [Related]
12. Aspirin to prevent heart attack and stroke: what's the right dose?
Dalen JE
Am J Med; 2006 Mar; 119(3):198-202. PubMed ID: 16490462
[TBL] [Abstract][Full Text] [Related]
13. Aspirin for primary prevention of cardiovascular disease events.
Nemerovski CW; Salinitri FD; Morbitzer KA; Moser LR
Pharmacotherapy; 2012 Nov; 32(11):1020-35. PubMed ID: 23019080
[TBL] [Abstract][Full Text] [Related]
14. [Primary prevention of cardiovascular diseases with acetylsalicylic acid].
Waltering A; Hemkens L; Florack C
Dtsch Med Wochenschr; 2005 Dec; 130(49):2847-52. PubMed ID: 16317615
[TBL] [Abstract][Full Text] [Related]
15. Aspirin for the primary prevention of adverse cardiovascular events.
Estes K; Thomure J
Crit Care Nurs Q; 2008; 31(4):324-39. PubMed ID: 18815480
[TBL] [Abstract][Full Text] [Related]
16. Low-dose aspirin for primary prevention of cardiovascular disease.
Bredie SJ; Wollersheim H; Verheugt FW; Thien T
Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
[TBL] [Abstract][Full Text] [Related]
17. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
18. [Statins and ASS for primary prevention of cardiovascular and cerebrovascular disease].
Goltz L; Bodechtel U; Siepmann T
Dtsch Med Wochenschr; 2014 Feb; 139(6):283-6. PubMed ID: 24473850
[TBL] [Abstract][Full Text] [Related]
19. [Aspirin for primary prevention of cardiovascular diseases--lessons from recent studies].
Balmor GR; Shoenfeld Y
Harefuah; 2010 Nov; 149(11):712-4, 749, 748. PubMed ID: 21250412
[TBL] [Abstract][Full Text] [Related]
20. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis.
Burger W; Chemnitius JM; Kneissl GD; Rücker G
J Intern Med; 2005 May; 257(5):399-414. PubMed ID: 15836656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]